Show/Hide Menu
Hide/Show Apps
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Communities & Collections
Communities & Collections
Help
Help
Frequently Asked Questions
Frequently Asked Questions
Guides
Guides
Thesis submission
Thesis submission
MS without thesis term project submission
MS without thesis term project submission
Publication submission with DOI
Publication submission with DOI
Publication submission
Publication submission
Supporting Information
Supporting Information
General Information
General Information
Copyright, Embargo and License
Copyright, Embargo and License
Contact us
Contact us
Metformin-Cisplatin combination treatment alters gene and protein expressions of CYP17A1 in LNCaP cell line
Date
2017-06-28
Author
Durukan, Özlem
Akkulak, Merve
Sena Gjota, Ergin
Arslan, Şevki
Adalı, Orhan
Metadata
Show full item record
Item Usage Stats
38
views
0
downloads
Cite This
URI
https://hdl.handle.net/11511/79143
Collections
Unverified, Conference / Seminar
Suggestions
OpenMETU
Core
Metformin – Cisplatin Combination Treatment Alters mRNA Expression of Hexokinase II Gene in LNCaP and PC3 Prostate Cancer Cell Lines
Durukan, Özlem; Evin, Emre; Arslan, Şevki; Adalı, Orhan (null; 2017-07-08)
Metformin is an antidiabetic drug with anticancer properties. Cisplatin is known as one of the most potent chemotherapeutics for treatment of various types of cancer. In order to overcome cisplatin resistance and toxicity, the drug can be combined with other chemotherapeutics that sensitize tumour cells to cisplatin. The ability of metformin to potentiate cisplatin-mediated killing of cancer cells in vitro, makes it a plausible candidate for combination with cisplatin-based therapy. The aim of this study is...
Metformin for prevention of hypertensive disorders of pregnancy in women with gestational diabetes or obesity: systematic review and meta-analysis of randomized trials
KALAFAT, ERKAN; ŞÜKÜR, YAVUZ EMRE; Abdi, A.; Thilaganathan, B.; Khalil, A. (2018-12-01)
Objective Metformin has been reported to reduce the risk of pre-eclampsia. It is also known to influence soluble fms-like tyrosine kinase-1 level, which correlates significantly with the gestational age at onset and severity of pre-eclampsia. The main aim of this systematic review and meta-analysis of randomized trials was to determine whether metformin use is associated with the incidence of hypertensive disorders of pregnancy (HDP).
Methacrylated gelatin hydrogels as corneal stroma substitutes: in vivo study
BEKTAŞ, CEMİLE; Burcu, Ayse; Gedikoglu, Gokhan; Telek, Hande H.; Ornek, Firdevs; Hasırcı, Vasıf Nejat (2019-09-20)
Methacrylated gelatin (GelMA) hydrogels were prepared to serve as corneal stroma equivalents. They were highly transparent (ca. 95% at 700 nm), mechanically strong and withstood handling and had high human corneal keratocyte viability (98%) after 21 days of culture period. In order to test the in vivo performance of the cell free GelMA hydrogels a pilot in vivo study was carried out using eyes of two white New Zealand rabbits. Hydrogel was implanted in a mid-stromal pocket created and without suture fixatio...
Methanol oxidation by nano Pt C electrocatalysts and DFT studies
Gökağaç Arslan, Gülsün; Çokangın, Aysu (2016-09-15)
Methomyl utilisation by methylotrophic bacteria
Özaslan, Deniz; Alaeddinoğlu, N. Gürdal; Demir, Ayhan S.; Department of Biotechnology (2001)
Citation Formats
IEEE
ACM
APA
CHICAGO
MLA
BibTeX
Ö. Durukan, M. Akkulak, E. Sena Gjota, Ş. Arslan, and O. Adalı, “Metformin-Cisplatin combination treatment alters gene and protein expressions of CYP17A1 in LNCaP cell line,” 2017, Accessed: 00, 2021. [Online]. Available: https://hdl.handle.net/11511/79143.